Jacobio Pharmaceuticals repurchases shares, boosts treasury holdings

On November 3, 2025, Jacobio Pharmaceuticals Group Co., Ltd. disclosed a repurchase of 53,100 ordinary shares on the Exchange. This transaction, executed at an average price of HK$7.21215 per share, resulted in an aggregate payment of HK$382,965.

Following this event, the company's number of issued shares (excluding treasury shares) decreased to 787,490,880. Conversely, the number of treasury shares increased by 53,100 to 4,264,200. The total number of issued shares for Jacobio Pharmaceuticals Group remains unchanged at 791,755,080.

The repurchase was conducted under a mandate granted on June 10, 2025, which authorized the company to repurchase up to 78,873,528 shares. To date, Jacobio Pharmaceuticals has repurchased 1,244,400 shares on the Exchange. A moratorium period for new share issues or sales of treasury shares after this repurchase extends until December 3, 2025.